✦ LIBER ✦

Long-Term Follow-up of Allogeneic Marrow Transplantation for Acute Myelogenous Leukemia after Treatment with Busulfan and Cyclophosphamide

✍ Scribed by Javier Bolaños-Meade; Eric Hartley; Richard J. Jones

Book ID: 116278460
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 81 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term leukemia-free survival after a

Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia

✍ H. T. Greinix; F. Keil; S. A. Brugger; E. Reiter; W. Linkesch; K. Lechner; B. Sc 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 595 KB

1129 Long-term follow-up of allogeneic m

1129 Long-term follow-up of allogeneic marrow transplantation for acute myeloid leukemia after cyclophosphamide-total body irradiation and cyclosporine

✍ Mehta, J.; Singhal, S.; Treleaven, J.; Horton, C.; Tait, D.; Powles, R. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Long-term follow-up of patients after re

Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia

✍ E. Reiter; H. T. Greinix; F. Keil; S. Brugger; W. Rabitsch; A. Schulenburg; C. M 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 125 KB

Risk of extramedullary relapse following

Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis

✍ Michel, G; Boulad, F; Small, T N; Black, P; Heller, G; Castro-Malaspina, H; Chil 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Long-term follow-up of a phase I study o

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

✍ Marcos de Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with high‐ris

Long-term follow-up of immunosuppressive

Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation

✍ Sánchez, J; Torres, A; Serrano, J; Román, J; Martín, C; Pérula, L; Martínez, F; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB